Seasonal Depression: When the Year Has a Low Season
Seasonal affective disorder (SAD) is a recurrent pattern of depressive episodes that follow a seasonal rhythm, typically beginning in autumn or early winter and remitting spontaneously in spring. It is classified in DSM-5 as a specifier of major depressive disorder rather than a separate diagnosis — the seasonal patterning occurs within the context of a mood disorder — but this technical distinction matters less for most people than the recognition that their mood follows the light, predictably and significantly, in a way that has a well-understood biological basis and evidence-based treatment.
Clinically significant SAD is estimated to affect 1–3% of the UK population, with a further 10–20% experiencing subsyndromal SAD — the winter blues — a milder but still functionally significant mood change that follows the same seasonal pattern. The latitude effect is real: rates of SAD increase with distance from the equator, reflecting the longer and more pronounced seasonal light variation at northern latitudes. This is not a cultural or psychological phenomenon; it is a biological response to light deprivation.
The neurobiological mechanism centres on the effects of reduced light exposure on the circadian system and on serotonin and melatonin regulation. Light reaches the brain through the retino-hypothalamic tract, providing the primary signal for the circadian clock. Reduced light exposure disrupts the circadian rhythm, affecting sleep-wake cycles, hormone release timing, and mood regulation. It also impairs the regulation of serotonin transporters, reducing synaptic serotonin. And it fails to suppress melatonin in the morning as bright light normally would, leaving melatonin elevated into the day and producing the fatigue, hypersomnia, and cognitive slowing that characterise SAD.
The symptom profile of SAD is distinctive within the depression spectrum. Unlike typical depression, SAD characteristically involves hypersomnia (sleeping more, not less), hyperphagia with specific carbohydrate craving, weight gain, and profound fatigue alongside low mood and social withdrawal. These atypical features reflect the specific mechanism — they are in part the expression of an extended winter physiology, an evolutionary adaptation to reduced-food and cold periods that produces a hibernate-like state.
The treatment evidence is more robust and more specific than for many conditions. Light therapy — a 10,000 lux full-spectrum light box used for 20–30 minutes in the morning — has the strongest and most consistent evidence base, with multiple meta-analyses showing effect sizes comparable to antidepressant medication. Timing matters: morning use is substantially more effective than evening use for circadian resetting. CBT adapted specifically for SAD (CBT-SAD), developed by Kelly Rohan and colleagues, has demonstrated efficacy in randomised trials and appears to provide more durable benefit than light therapy alone. SSRIs are also effective. Vitamin D supplementation, despite its common association with SAD, has a weaker and more mixed evidence base than is often assumed — it addresses a possible contributing deficit but is not the primary mechanism. Maia, the AI companion in Asclepiad, offers space for understanding why winter feels so different.
Frequently Asked Questions
Is Asclepiad designed for seasonal depression?
Asclepiad is well-suited to understanding seasonal depression — the neurobiological mechanism, the distinctive symptom profile, and what the treatment evidence says. For treatment, a 10,000 lux light box is widely available and is the first-line recommendation; a GP referral can access antidepressant medication or CBT-SAD; the SAD Association (sada.org.uk) provides information and peer support.